Next Article in Journal
Beyond X-Rays: Unveiling the Future of Dental Diagnosis with Dental Magnetic Resonance Imaging
Previous Article in Journal
Visualizing Aortic Inflammation by Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Predictive Validity of Screening Tools and Role of Self-Esteem and Coping in Postpartum Depression Risk

by
Nadica Motofelea
1,2,3,
Alexandru Catalin Motofelea
1,4,*,
Ionela Florica Tamasan
5,
Teodora Hoinoiu
3,6,
Jabri Tabrizi Madalina Ioana
1,3,6,
Maja Vilibić
7,8,
Antoniu Ionescu Cringu
9,10,
Brenda Cristiana Bernad
1,11,
Sorin Trinc
12 and
Dan-Bogdan Navolan
2
1
Doctoral School, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
2
Department of Obstetrics and Gynecology, “Victor Babes” University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
3
Department of Clinical Practical Skills, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
4
Center of Molecular Research in Nephrology and Vascular Disease, “Victor Babes” University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
5
Department XI: Pediatrics, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
6
Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
7
Department of Psychiatry, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia
8
School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia
9
Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
10
Saint Pantelimon Clinical Emergency Hospital, 020021 Bucharest, Romania
11
Center for Neuropsychology and Behavioral Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
12
Department of Microscopic Morphology, Genetics Discipline, Center of Genomic Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
*
Author to whom correspondence should be addressed.
Diagnostics 2025, 15(9), 1152; https://doi.org/10.3390/diagnostics15091152
Submission received: 25 March 2025 / Revised: 27 April 2025 / Accepted: 29 April 2025 / Published: 30 April 2025
(This article belongs to the Section Clinical Diagnosis and Prognosis)

Abstract

:
Background/Objectives: Postpartum depression (PPD) is a prevalent mental health disorder affecting women after childbirth, with significant adverse effects on both maternal and infant outcomes. Early detection and intervention are critical to improving health trajectories. Material and Methods: This narrative review compares the predictive validity of commonly used screening instruments for PPD, including the Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 (PHQ-9), and brief tools like PHQ-2 and PHQ-4. It also examines the role of self-esteem, assessed using the Rosenberg Self-Esteem Scale (RSES), and coping mechanisms, evaluated through the COPE Inventory, in moderating PPD risk. Results: Validation studies reveal variability in the performance of screening tools across different populations, emphasizing the need for contextual calibration. Low self-esteem and maladaptive coping strategies are consistently associated with higher PPD risk, with socioeconomic status (SES) further influencing these relationships. Interventions focusing on enhancing self-esteem and promoting adaptive coping, such as cognitive–behavioral therapy and psychoeducation, show promise in reducing PPD incidence. Conclusions: This review highlights gaps in existing research, particularly regarding screening during pregnancy, and calls for integrated predictive models incorporating psychosocial variables. Early, context-sensitive screening approaches are essential for effective PPD prevention and management.

1. Introduction

Postpartum depression (PPD) is a prevalent and often underdiagnosed mental health condition affecting women after childbirth, with reported prevalence rates ranging from approximately 7% to 30% in various studies [1,2,3,4]. If left untreated, PPD can adversely affect the mother’s well-being and the child’s emotional, mental, and intellectual development [5]. In the long term, mothers with PPD may face increased risks of chronic diseases and recurrent depressive episodes [6]. Studies have also shown that untreated PPD may lead to difficulties in bonding with the infant, potentially impairing the parent–child relationship and affecting long-term emotional development [7,8,9]. Thus, the early detection and provision of support are crucial in fostering positive health outcomes for both mothers and their children. Despite a broad consensus among health organizations regarding the need for routine screening in perinatal care, many guidelines still lack specificity on the practical details required to ensure effective implementation. For instance, while the American College of Obstetricians and Gynecologists (ACOG) states that “routine screening by physicians is important for ensuring appropriate follow-up and treatment” (2023) [10], it offers limited directives on how and when this should be carried out. In contrast, the UK’s National Institute for Health and Care Excellence (NICE) provides more granular guidelines by specifying who should screen (the primary provider), at which intervals screening should occur (upon first contact, at 4–6 weeks, and 3–4 months postpartum), and which questions to use [11]. Even with these guidelines, however, there remains considerable variability in actual clinical practice, partly due to uncertainty about which screening instruments perform best in predicting PPD across diverse populations.
Research consistently supports the EPDS as a leading instrument for perinatal depression, showing high sensitivity (around 89.6%) and acceptable specificity—especially with a cutoff score of 8 [12,13]. Nonetheless, other instruments (PHQ-2, PHQ-4, Beck Depression Inventory, and Antepartum Questionnaire) remain in use. Comparative data on these tools—particularly in pregnant populations—are limited, and it is unclear which performs best across different cultural, socioeconomic, and clinical contexts [14,15,16,17]. Some studies have started to explore the combined use of these tools, with some showing that a multi-instrument approach may enhance detection rates, particularly in high-risk populations [18,19,20]. Emerging evidence highlights the impact of psychosocial factors, particularly self-esteem and coping mechanisms, on postpartum depression (PPD). Self-esteem, an individual’s assessment of their worth, is linked to mental health outcomes during the perinatal period. Low self-esteem, measured using the Rosenberg Self-Esteem Scale (RSES), correlates with increased depressive symptoms in postpartum women [21,22,23,24,25,26]. Adaptive coping strategies, evaluated through the COPE Inventory, have been shown to mitigate psychological strain and reduce PPD risk by managing stress and emotional challenges.
The aim of this review is to evaluate the predictive validity of widely used PPD screening instruments, particularly the EPDS and PHQ-9, in pregnant and postpartum populations. Additionally, the review explores the influence of psychosocial factors—specifically self-esteem and coping strategies, as measured by the RSES and COPE Inventory—on PPD risk. Finally, it examines how socioeconomic status interacts with these variables, with the goal of identifying gaps in existing screening practices and recommending integrated, context-sensitive approaches for the early detection and prevention of postpartum depression.

2. Materials and Methods

2.1. Literature Search Strategy

A comprehensive literature search was conducted to identify studies evaluating screening instruments for postpartum depression (PPD) and their integration with psychosocial measures such as self-esteem and coping mechanisms. The search spanned electronic databases including PubMed, PsycINFO, Web of Science, Scopus, and MedLine, covering the period from January 1987 to December 2024. Keywords and Medical Subject Headings (MeSH) terms were combined using Boolean operators (AND, OR) and included terms such as “postpartum depression”, “perinatal depression”, “screening”, “Edinburgh Postnatal Depression Scale (EPDS)”, “Patient Health Questionnaire-9 (PHQ-9)”, “PHQ-2”, “PHQ-4”, “Rosenberg Self-Esteem Scale”, “COPE Inventory”, “predictive validity”, “self-esteem”, “coping mechanisms”, and “socioeconomic status”.

2.2. Inclusion and Exclusion Criteria

Two independent reviewers screened the titles and abstracts of all identified articles, and full-text articles were subsequently assessed for eligibility according to the defined inclusion and exclusion criteria. Discrepancies between reviewers were resolved through discussion and consensus. Data extracted from each study included study characteristics (such as author(s), publication year, country, study design, and sample size), participant demographics (including age, stage of pregnancy or postpartum period, and socioeconomic status), the specific screening instruments evaluated along with their validation metrics, details regarding the assessment of self-esteem and coping strategies, and any reported interactions between these psychosocial measures and the performance of depression screening tools. The extracted data were organized in summary tables to facilitate a comparative analysis (Table 1).
A narrative synthesis was then conducted to compare the predictive validity of the various screening tools. Data were tabulated to highlight key metrics such as sensitivity, specificity, and cutoff values across different populations and settings. In addition, the review examined how psychosocial variables, specifically self-esteem and coping strategies, moderated or mediated the performance of these screening tools and influenced postpartum depression outcomes. Due to heterogeneity in study populations, methodologies, and outcomes, a formal meta-analysis was not performed. Instead, the findings were synthesized descriptively, with the aim of informing recommendations for clinical practice and guiding future research.

2.3. Screening Instruments Included in the Review

2.3.1. Edinburgh Postnatal Depression Scale (EPDS)

The EPDS is a 10-item self-report questionnaire specifically developed to assess depressive symptoms in postpartum women, with each item scored on a scale from 0 to 3 [27]. Its design focuses on capturing the unique emotional and psychological experiences of new mothers, distinguishing it from more general depression scales. The EPDS has been rigorously validated worldwide and translated into numerous languages, which makes it a cornerstone in both clinical practice and research. Studies have demonstrated its sensitivity to treatment effects; for example, research evaluating the efficacy of zuranolone showed statistically significant improvements in depressive symptoms as early as Day 3, with reductions sustained through Day 45 in comparison to the placebo [28]. Furthermore, the EPDS has been validated against established instruments such as the Center for Epidemiologic Studies-Depression Scale (CES-D) [29] and is adaptable to different cultural contexts—an essential feature for its use in diverse populations.

2.3.2. Patient Health Questionnaire-9 (PHQ-9)

The PHQ-9 is a widely utilized instrument that consists of nine items aligned with the diagnostic criteria for major depression [30]. It offers a quantitative measure of depressive symptom severity and has demonstrated high internal consistency and reliability in large, diverse samples [31]. Evidence supports the PHQ-9’s responsiveness to clinical change, with significant improvements in scores observed at various time points, such as Days 8, 15, and 45 in treatment studies [28]. However, it is important to note that the optimal cutoff scores for the PHQ-9 may vary by population, necessitating contextual calibration to ensure its accuracy and clinical utility.

2.3.3. Generalized Anxiety Disorder-7 (GAD-7)

While the GAD-7 is not a depression-specific instrument, it plays a critical role in assessing generalized anxiety symptoms, which are commonly observed alongside depression in postpartum populations. This 7-item scale provides a rapid evaluation of anxiety severity and is frequently used in conjunction with depression measures like the PHQ-9 to offer a more comprehensive picture of maternal mental health. The GAD-7’s brevity and ease of administration make it especially valuable in busy clinical settings, where prompt identification of anxiety symptoms can guide further evaluation and intervention.

2.3.4. Brief Screening Tools: PHQ-2 and PHQ-4

For initial screening purposes, shorter instruments such as the PHQ-2 and PHQ-4 are sometimes employed. The PHQ-2, a two-item version derived from the PHQ-9, is useful for a quick assessment but may not detect milder forms of depression as effectively [32]. In contrast, the PHQ-4 combines the two items of the PHQ-2 with an additional two items from the GAD-2, thereby screening simultaneously for both depression and anxiety [33,34,35,36,37,38,39]. Although these brief tools can enhance screening efficiency, they must be used with an understanding of their limitations, particularly regarding sensitivity.

3. Results

Together, these instruments form the backbone of postpartum mental health screening. Their validation across various populations and settings underscores their importance in early identification, which is critical for timely intervention and improved maternal and child outcomes.
The comparative evidence from these validation studies illustrates the variability in performance of the EPDS (and, in one case, the PHQ-9) across different populations and settings. For instance, studies in the United States, such as the one by Beck et al., 2001 [40], reported high specificity (0.99) for the EPDS using a cutoff of ≥12 in postpartum women. In contrast, Flynn et al., 2011 [41], observed high sensitivity (0.92) but lower specificity (0.54) in postpartum women using a cutoff of ≥13. Similarly, in pregnant populations, Su et al., 2001 [21], in Taiwan and Castro et al., 2015 [42], in Brazil demonstrated good sensitivity (0.83 and 0.81, respectively) with varying cutoff scores (≥13 and ≥11) and specificities (0.89 and 0.74, respectively).
The evidence also underscores the importance of contextual calibration—optimal cutoff scores may differ based on demographic and cultural factors, as well as the stage of pregnancy or postpartum period. Moreover, the performance of the PHQ-9 in postpartum populations (as seen in Flynn et al. [41]) indicates that while it reliably detects depressive symptoms (sensitivity of 0.89), its specificity (0.64) might require adjustment for certain clinical settings.
Collectively, these findings highlight the need for standardized evaluation protocols and careful consideration of population-specific factors when deploying these screening instruments in clinical practice. Ensuring accurate identification of at-risk individuals is crucial for timely intervention, ultimately improving maternal and child health outcomes (Table 2).
The studies summarized here illustrate a wide range of PHQ-9 performance characteristics in perinatal populations, with varying sensitivities and specificities based on sample demographics and chosen cutoffs. For example, Hanusa et al., 2008 [43], found relatively low sensitivity (0.31) and specificity (0.06) among 29 postpartum women at a cutoff of ≥10, whereas Flynn et al., 2011 [41], reported much higher sensitivity (0.89) at the same cutoff in a different U.S. postpartum sample. Gawlik et al., 2013 [47], demonstrated moderate sensitivity (0.40) but high specificity (0.92) in pregnant women at a cutoff of ≥10. Green et al., 2018 [53], in Kenya, tested a higher cutoff (≥15) and found balanced but moderate sensitivity (0.70) and specificity (0.74). Meanwhile, van Heyningen et al., 2018 [54], in South Africa, observed a sensitivity of 0.80 and specificity of 0.82 at ≥10 in pregnant women, suggesting that the PHQ-9 can perform well in low- and middle-income settings with appropriate calibration.
Collectively, these findings highlight that the optimal PHQ-9 cutoff can differ by context and population. Differences in cultural norms, the timing of assessment (pregnancy vs. postpartum), and sample characteristics (age, socioeconomic status) may account for variability in diagnostic accuracy. Consequently, clinicians and researchers should consider local validation studies or pilot testing to determine the most appropriate PHQ-9 threshold for identifying perinatal depression in a given setting (Table 3).

4. Discussion

This study aimed to evaluate the predictive validity of postpartum depression (PPD) screening tools and to explore the critical psychosocial factors—particularly self-esteem, coping strategies, and socioeconomic influences—that affect maternal mental health outcomes. Our findings highlight the variable performance of validated screening instruments across different populations, emphasizing the need for contextual calibration. Furthermore, the results demonstrate that self-esteem and coping mechanisms are not only independently associated with postpartum depression but also interact with socioeconomic factors to shape maternal vulnerability. In the following sections, we discuss the results according to the specific objectives of the study, drawing on the existing literature to interpret their clinical and public health implications (Figure 1).

4.1. Predictive Validity of Screening Tools for PPD

This review highlights the crucial role of validated screening instruments such as the Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 (PHQ-9), PHQ-2, and PHQ-4 in the early identification of postpartum depression (PPD). The evidence demonstrates considerable variability in sensitivity and specificity across studies, reflecting differences in demographics, timing (pregnancy vs. postpartum), and cultural context. For instance, Beck et al., 2001 [46], reported high specificity (0.99) for the EPDS at a cutoff of ≥12 in U.S. postpartum women, while Flynn et al., 2011 [41], found high sensitivity (0.92) but lower specificity (0.54) at a cutoff of ≥13. Similarly, PHQ-9 performances ranged widely, from low sensitivity (0.31) and specificity (0.06) in Hanusa et al., 2008 [43], to balanced performance (sensitivity 0.80; specificity 0.82) in van Heyningen et al., 2018 [54]. These results emphasize the necessity of the contextual calibration of screening tools to ensure effective identification of at-risk individuals in diverse settings. Including brief tools such as PHQ-2 and PHQ-4 can enhance initial screening efficiency, but they must be used cautiously due to limitations in detecting milder depression.

4.2. Interactions Between Self-Esteem, Coping, and Socioeconomic Status

The COPE Inventory, originally developed by Carver, Scheier, and Weintraub, 1989 [55], is a comprehensive, multidimensional tool that assesses a range of coping strategies employed by individuals facing stress. It encompasses various subscales that differentiate between adaptive and maladaptive coping responses.
Adaptive coping strategies—such as active coping, planning, seeking instrumental support, and positive reframing—are considered constructive approaches that help individuals manage stress effectively. In perinatal populations, these adaptive methods have been linked to lower levels of postpartum depressive symptoms. For instance, research among postnatal mothers in Malaysia demonstrated that problem-focused coping strategies were negatively correlated with depressive symptoms [56]. Similarly, studies in Chinese populations have shown that positive coping styles, including detailed planning and active seeking of social support, are associated with reduced levels of postpartum depression [26].
In contrast, maladaptive coping strategies such as denial, behavioral disengagement, self-blame, and emotion-focused coping are generally less effective in alleviating stress and may even exacerbate negative emotional outcomes. Evidence from a study among postpartum women in Brazil indicated that avoidant strategies, such as distancing oneself from the stressor, were linked to increased depressive symptoms [25]. Likewise, research among Korean mothers found that emotion-focused coping strategies, including persistent rumination, were more prevalent in individuals experiencing postpartum depression [57].
By distinguishing between these two types of coping strategies, the COPE Inventory provides valuable insights into how different coping styles can influence mental health outcomes. This understanding is particularly important for developing targeted interventions aimed at promoting adaptive coping mechanisms, thereby potentially reducing the risk or severity of postpartum depression.
Interactions between self-esteem, coping, and socioeconomic status play a critical role in shaping the risk and severity of postpartum depression (PPD). Low self-esteem emerges as a potent contributor to maladaptive coping. Women who view themselves negatively or feel incompetent as new mothers are more likely to engage in avoidant behaviors—such as denying issues or withdrawing—and adopt self-punitive strategies like self-blame, which can maintain or worsen depressive symptoms [58,59]. In contrast, higher self-esteem facilitates the use of adaptive coping strategies, such as reaching out for help and actively problem-solving, which can act as a buffer against severe PPD [26,60]. The evidence suggests that low self-esteem and poor coping mutually reinforce one another, creating a cycle that clinical interventions must strive to break.
Different coping strategies have distinct impacts on maternal mental health. Maladaptive approaches, including avoidance, substance use, and self-blame, are frequently associated with higher levels of PPD across diverse populations; these behaviors often reflect an overwhelmed or undervalued self, leading to functional impairments in a mother’s life [59,61]. Conversely, problem-focused coping and constructive emotion-focused strategies—such as seeking social support—are linked to less severe depressive symptoms. However, depressed mothers tend to underutilize these adaptive strategies, possibly due to cognitive biases (e.g., “no one can help me” or “I don’t deserve help”) that stem from low self-worth [25]. Therapeutically, these findings underscore the importance of teaching positive coping skills in postpartum depression treatment. For example, cognitive–behavioral therapy can reduce self-blame and avoidance by helping mothers reframe negative thoughts and engage step-by-step with their problems.
Socioeconomic status (SES) further modulates coping options and outcomes. Women with low SES often face heavier burdens such as financial strain, limited social support, and greater stigma or lack of knowledge about PPD. These factors can push them toward more passive, emotion-focused coping strategies. Although endurance or informal support, such as family or faith, may sometimes provide relief, they are frequently insufficient, especially in severe cases. In higher-SES populations, women generally have greater opportunities to choose active coping methods (e.g., attending mommy-and-me psychotherapy groups or hiring a babysitter for respite), which tend to yield better outcomes. Nonetheless, even in these groups, vulnerability to maladaptive coping persists if depressive symptoms occur. Overall, while the fundamental patterns of how self-esteem and depression interact appear similar across SES groups, the extent to which adaptive coping strategies can be activated is often lower in disadvantaged populations due to external barriers [25,62].
Low SES not only predisposes women to chronic stress by limiting resources and social support but also interacts with self-esteem to elevate the risk of PPD. For example, studies have found that financial stress and a lack of social support are significant predictors of postpartum depression among low-SES women [63]. Similarly, research among Chinese women indicates that lower educational levels correlate with a higher likelihood of engaging in maladaptive coping strategies, such as avoidance, which are associated with increased levels of PPD [26].
Moreover, several studies demonstrate that self-esteem moderates the relationship between coping and PPD risk. Research indicates that women with an external locus of control—who attribute their health outcomes to chance—are at higher risk of developing PPD. An intervention study in Iran showed that reducing chance in the health locus of control while increasing internal control improved psychological health and prevented PPD [64]. In addition, cross-sectional data reveal that problem-focused coping strategies are significantly influenced by factors such as age, the gender of children, and avoidant-focused coping, with women undergoing cesarean sections being more prone to avoidant coping, which is less effective for managing PPD symptoms [64,65]. These findings suggest that promoting an internal locus of control and encouraging problem-focused coping may lead to better mental health outcomes for women at risk of or experiencing PPD. Tailoring support based on individual factors—such as age, delivery method, and family composition—may further enhance the effectiveness of coping strategies in managing postpartum depressive symptoms.
Low self-esteem, maladaptive coping, and socioeconomic stressors form a triad that can jointly exacerbate postpartum depression. Modern research underscores that interventions for PPD should be holistic, incorporating strategies to bolster self-esteem through counseling and positive feedback, teaching effective coping skills such as problem-solving and help-seeking, and reducing socioeconomic barriers by improving access to affordable mental health resources and community support. By targeting each element of this triad, healthcare providers can design more effective prevention and treatment strategies for postpartum depression, ultimately improving outcomes for mothers and their families [26,58]. Given the importance of emotional resilience, it is crucial to understand how self-esteem and coping mechanisms interact, particularly in populations facing socioeconomic challenges.

4.3. Neurobehavioral Underpinnings of Self-Esteem and Coping

Building on the psychosocial patterns identified earlier, emerging evidence indicates that the neurobiological basis of self-esteem and coping mechanisms is closely tied to stress regulation systems, particularly the hypothalamic–pituitary–adrenal (HPA) axis. Chronic stress—especially prevalent during the perinatal period—can dysregulate the HPA axis, leading to sustained elevations in cortisol levels and maladaptive neuroplastic changes. Longitudinal human studies have shown that higher chronic stress during pregnancy and postpartum correlates with increased hair cortisol concentrations, suggesting prolonged biological stress activation [66].
Prolonged HPA axis activation is associated with hippocampal atrophy, amygdala hyperactivity, and prefrontal cortex dysfunction—brain regions critical for self-evaluation, emotional regulation, and adaptive coping [67,68]. Recent neuroimaging research in postpartum women reveals structural changes in the hippocampus and amygdala that are linked to perinatal depression symptoms [69]. Similarly, functional MRI studies have documented disrupted connectivity between the amygdala and prefrontal circuits, with postpartum depressed women showing exaggerated emotional reactivity and impaired regulation [70].
These stress-related neuroplastic changes have profound psychological implications. Impairments in hippocampal and prefrontal function can reduce cognitive flexibility and self-regulation, making individuals more vulnerable to persistent negative self-appraisals and maladaptive coping strategies such as rumination and avoidance. For example, mothers with heightened stress responses may exhibit greater emotional reactivity and struggle to engage in effective problem-solving or support-seeking behaviors, thereby reinforcing depressive cycles [71,72].
Maladaptive coping strategies, in turn, can further impair biological stress recovery. Rumination, for instance, has been shown to prolong cortisol elevations after stress exposure, “locking” the HPA axis into a dysregulated state and preventing normal physiological recovery [71,72]. In perinatal populations, avoidant coping and emotion-focused coping have been associated with both heightened stress markers and worse depressive outcomes [73].
Thus, the interplay between chronic stress, neuroplastic brain changes, and impaired coping creates a self-perpetuating cycle that exacerbates maternal vulnerability to postpartum depression. Interventions targeting both cognitive–emotional restructuring and physiological stress regulation—such as cognitive–behavioral therapy (CBT) combined with stress reduction techniques—may offer a more integrated and effective approach to promoting maternal mental health.
Understanding these neurobehavioral pathways emphasizes the importance of the early detection of psychosocial risk factors (such as low self-esteem and maladaptive coping) and highlights the value of preventive strategies that aim not only to modify thoughts and behaviors but also to restore biological homeostasis during the perinatal period.

4.4. Self-Esteem in Pregnancy and Postpartum: Assessment, Risks, and Intervention Strategies

The Rosenberg Self-Esteem Scale (RSES) is a widely recognized instrument for assessing global self-esteem, defined as a person’s overall evaluation of their worth or value. Comprising ten items rated on a four-point Likert scale, the RSES captures both positive and negative dimensions of self-perception. According to Rosenberg’s theoretical framework, individuals with high self-esteem tend to perceive themselves as valuable and competent, whereas those with low self-esteem are more prone to feelings of isolation, guilt, and diminished self-worth [74,75].
Self-esteem, often termed self-respect, is a psychological concept that reflects an individual’s positive or negative attitude toward themselves [76,77]. As Rosenberg notes, individuals with high self-esteem recognize and appreciate their own worth [74]. He believes that such individuals see and respect themselves as valuable people [74]. Self-esteem is important, as shown by its special place in Maslow’s hierarchy [75]. A lack of self-esteem can lead to various issues in social relationships [78] and affect people’s interactions with others [78]. Feelings of isolation and guilt often accompany sexual dysfunction, eating disorders [79], anxiety [80], and depression [81]. Self-esteem can fluctuate throughout life [80], and pregnancy is a period when women frequently experience low self-esteem due to the physiological, anatomical, and psychological changes they undergo [23]. A lack of self-esteem is associated with poor mental and physical health in mothers, which negatively impacts infant health and the mother–infant attachment [21,22].
Numerous factors contribute to the development of self-esteem, including genetics, age, socioeconomic status, thought patterns [24], health conditions, parental influence, childhood experiences, and more [80]. Research indicates that dissatisfaction with body image among Iranian women has significantly increased in recent years [82]. Much like self-esteem, body image evolves throughout a woman’s life, encompassing phases such as menstruation, pregnancy [83,84], breastfeeding, and the postpartum period [85]. A negative body image can lead to feelings of unattractiveness, dissatisfaction in marital relationships [86], depression [87], eating disorders, and low self-esteem [88]. Postpartum depression is more prevalent among women with a negative body image [89]. Likewise, mothers unhappy with their postpartum body image tend to have a more negative attitude toward breastfeeding [90].
Self-esteem [91] and body image are among the most significant factors affecting exclusive breastfeeding. Currently, only 40% of infants worldwide are exclusively breastfed. This is concerning, as UNICEF reports that increasing exclusive breastfeeding rates could save over 80,000 infants under the age of five from death [92]. It has been noted that women who are confident and receive adequate support from family and others tend to have a positive and sustained breastfeeding experience [93]. According to the World Health Organization (WHO), initiating and continuing breastfeeding requires counseling, along with supportive and promotional programs [94].
Counseling is a process that helps enhance an individual’s attitude, behavior, and personality. Additionally, it improves communication skills, facilitates behavior change, and boosts mental health and self-esteem empowerment [93]. CBT is a counseling technique that can be employed on its own or alongside other methods to address personality disorders, mental disorders, depression, anxiety, and poor body image [95]. In this approach, the therapist does not question the client’s feelings but instead challenges the thoughts that give rise to these feelings, explaining to clients how their thoughts lead to their emotions [96]. This method instructs mothers to refrain from prejudgment and negative assessments, encouraging them to exhibit appropriate emotional responses during stressful situations such as pregnancy, breastfeeding, and the postpartum period [96]. Through a review of the literature, we concluded that CBT is likely effective in boosting self-esteem and enhancing body image. For instance, forensic research utilizing Mekereș’ Psychosocial Internalization Scale (MPIS) has demonstrated that the psychosocial impact of post-traumatic and surgical scars—manifested in diminished self-esteem and self-confidence—can adversely affect social functioning and overall well-being [97,98,99,100]. Given the established links among low self-esteem, negative body image, and adverse health outcomes, our study investigates the effects of cognitive–behavioral pregnancy counseling on self-esteem and body image (primary outcomes) and exclusive breastfeeding (secondary outcome). Given some women’s low self-esteem and impaired body image, as well as the impact of these two factors on exclusive breastfeeding, we decided to investigate the effects of cognitive–behavioral pregnancy counseling on self-esteem, body image (primary outcomes), and exclusive breastfeeding (secondary outcome).
Studies have shown that low self-esteem correlates with higher levels of postpartum depressive symptoms, suggesting that the RSES can serve as a useful predictor of postpartum depression (PPD). In one longitudinal study of pregnant women, those who reported higher self-esteem on the RSES during gestation experienced fewer depressive symptoms in the postpartum period [21,22]. Conversely, women with lower self-esteem scores were more vulnerable to stressors such as physiological and psychological changes, leading to an increased risk of PPD [23,24].
RSES stands out as a brief yet robust tool for evaluating a key psychosocial factor that can either protect against or exacerbate postpartum depression. By integrating self-esteem assessment into routine prenatal or early postpartum screening, healthcare providers can identify at-risk mothers and offer targeted interventions—such as cognitive–behavioral therapy or psychoeducation—that aim to bolster self-esteem and mitigate the onset or severity of PPD.

4.5. Relationship Between Coping Strategies and PPD Outcomes

The present study highlights the role of self-esteem in shaping how women cope with stress during the postpartum period and, consequently, in influencing depressive outcomes. Our findings suggest that self-esteem acts as a protective factor against stress, with higher self-esteem associated with adaptive coping strategies, such as active problem-solving and seeking social support, which help reduce stress’s negative effects. In contrast, low self-esteem appears to contribute to maladaptive coping mechanisms, including avoidance and substance use, ultimately heightening stress levels and increasing the risk of depressive symptoms. Conversely, low self-esteem appears to predispose individuals to maladaptive coping mechanisms, including avoidance and substance use, thereby exacerbating stress and increasing the risk of depressive symptoms [101,102,103].
Consistent with prior research among college students, our synthesis confirms that low self-esteem is associated with heightened perceived stress, which in turn predisposes individuals to depression [101,104]. In the context of postpartum depression (PPD), these findings are particularly salient. Women with higher self-esteem demonstrate a greater propensity to engage in adaptive coping behaviors, such as seeking social support and practicing self-care, which are linked to lower levels of depressive symptoms [105,106].
Social support emerges as a key mediating factor in this relationship. Higher social support levels correlate with increased self-esteem and reduced depressive symptoms [105,106]. This suggests that interventions designed to strengthen social networks may indirectly bolster self-esteem and promote more adaptive coping responses. Additionally, attachment styles and family support further moderate this dynamic; individuals with secure attachment and robust family support tend to maintain higher self-esteem and experience fewer depressive symptoms compared to those with insecure attachment or limited support.
Our review also highlights the buffering effect of self-esteem on the negative consequences of neuroticism and chronic stress. In studies involving older adults, higher self-esteem was associated with reduced distress in the presence of personality vulnerabilities [102]. This protective role is likely even more critical for postpartum women, who often face elevated stress levels and neuroticism during this period. Moreover, the reciprocal relationship observed between self-esteem and anxiety—where low self-esteem both predicts and is exacerbated by anxiety symptoms—underscores the potential of interventions targeting self-esteem to simultaneously alleviate both anxiety and depressive symptoms [107].
Furthermore, research indicates that fluctuations in self-esteem, alongside transient changes in loneliness and stress, can predict short-term variations in depressive states [103]. Such findings reinforce the importance of continuous monitoring and support throughout the postpartum period. Evidence from diverse populations, including university students and family caregivers, further solidifies low self-esteem as a robust predictor of depressive symptoms [108,109]. This broadens the relevance of our findings, suggesting that self-esteem is a central construct not only in PPD but across varied contexts where stress and depression are prominent.
In addition to individual psychological factors, external stressors such as caregiving burdens and socioeconomic challenges also play a significant role. Women facing substantial external pressures are more likely to exhibit lower self-esteem and, consequently, engage in maladaptive coping strategies. The triadic relationship among self-esteem, coping mechanisms, and socioeconomic status emphasizes the need for multifaceted intervention approaches that address both internal and external determinants of PPD.
Interventions aimed at enhancing self-esteem and strengthening social support networks may promote adaptive coping strategies, ultimately reducing the incidence and severity of postpartum depression. Future research should employ longitudinal designs to further elucidate the causal pathways among self-esteem, coping strategies, and PPD, and evaluate the efficacy of integrated intervention models that address both psychosocial and socioeconomic determinants of maternal mental health.

4.6. Clinical Implications and Future Directions

Building upon the synthesis of screening performance, psychosocial factors, and socioeconomic influences discussed above, the findings of this review underscore the need for a comprehensive and multidimensional approach to the prevention, early identification, and management of postpartum depression (PPD). Screening tools such as the EPDS and PHQ series are valuable first steps, but their effectiveness increases significantly when combined with assessments of psychosocial factors like self-esteem, coping strategies, and socioeconomic challenges.
Healthcare providers should integrate self-esteem evaluations, such as the Rosenberg Self-Esteem Scale (RSES), into routine prenatal and postpartum care to identify women at risk of adverse mental health outcomes. Early interventions, particularly those based on cognitive–behavioral therapy (CBT), may enhance self-esteem, promote positive body image, strengthen adaptive coping mechanisms, and reduce depressive symptoms.
Given the demonstrated interaction between socioeconomic status, self-esteem, and coping strategies, particular attention should be given to women from disadvantaged backgrounds. Programs that improve access to social support networks, mental health resources, and educational interventions about coping strategies can play a critical role in mitigating PPD risk.
Future research should prioritize longitudinal designs to better establish causal relationships between self-esteem, coping mechanisms, socioeconomic status, and postpartum depression outcomes. Moreover, studies investigating culturally sensitive and context-specific interventions are essential to address the diverse needs of maternal populations worldwide. Integrated models that combine psychological support with socioeconomic empowerment strategies are likely to yield the greatest improvements in maternal and infant health.

5. Conclusions

This review highlights the critical role of self-esteem and coping strategies as key psychosocial determinants of maternal mental health, particularly in the context of postpartum depression (PPD). Low self-esteem was consistently associated with higher vulnerability to depressive symptoms, impaired maternal–infant bonding, and maladaptive coping mechanisms. Our findings emphasize that screening tools such as the EPDS and PHQ-9 are valuable for early detection, but their predictive validity can be significantly enhanced when integrated with assessments of self-esteem and coping behaviors. A holistic, multidimensional approach to maternal mental health—one that addresses emotional resilience, adaptive coping, and socioeconomic barriers—is essential for effective PPD prevention and management. Clinical practice should prioritize the early identification of psychosocial risk factors alongside standard depression screening, offering targeted interventions such as cognitive–behavioral therapy and psychosocial support programs. This review also acknowledges certain limitations, including the narrative nature of the synthesis and variability across included studies in terms of methodology and population diversity. Future research should prioritize longitudinal designs to establish causal pathways and validate integrated screening models across culturally and socioeconomically diverse populations. Ultimately, improving maternal mental health requires not only clinical vigilance but also proactive psychosocial empowerment, ensuring that prevention, early intervention, and support strategies are tailored to the complex realities faced by new mothers worldwide.

Author Contributions

Conceptualization, N.M. and A.C.M.; methodology, N.M. and I.F.T.; software, J.T.M.I.; validation, T.H., M.V. and A.I.C.; formal analysis, B.C.B.; investigation, A.C.M. and S.T.; resources, T.H.; data curation, I.F.T.; writing—original draft preparation, N.M. and A.C.M.; writing—review and editing, A.I.C., M.V. and D.-B.N.; visualization, J.T.M.I.; supervision, A.I.C. and D.-B.N.; project administration, N.M.; funding acquisition, N.M. All authors have read and agreed to the published version of the manuscript.

Funding

We would like to acknowledge “Victor Babes” University of Medicine and Pharmacy for their support in covering the costs of publication for this research paper.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Usmani, S.; Javed, S.; Ferrer, G.; Sarfraz, Z.; Mohammadi, A.; Greca, E.; Sharath, M.; Hussaini, S.S.; Cabrera, E.; Salari, S.W.; et al. Risk Factors for Postpartum Depression During COVID-19 Pandemic: A Systematic Literature Review. J. Prim. Care Community Health 2021, 12, 1–9. [Google Scholar] [CrossRef]
  2. Liang, P.; Wang, Y.; Xiong, R.; Shi, S.; Liu, Y. Prevalence and Factors Associated with Postpartum Depression during the COVID-19 Pandemic among Women in Guangzhou, China: A Cross-Sectional Study. BMC Psychiatry 2020, 20, 557. [Google Scholar] [CrossRef]
  3. Vo, T.V.; Hoa, T.K.D.; Hoang, T.D. Postpartum Depressive Symptoms and Associated Factors in Married Women: A Cross-Sectional Study in Danang City, Vietnam. Front. Public Health 2017, 5, 93. [Google Scholar] [CrossRef]
  4. Postpartum Depression and Risk Factors Among Working Women One Year After Delivery in Beijing, China: A Cross-Sectional Study—R Discovery. Available online: https://discovery.researcher.life/article/postpartum-depression-and-risk-factors-among-working-women-one-year-after-delivery-in-beijing-china-a-cross-sectional-study/0b0329f1d51e36998eee7ea8afe5e00c?eos_user_id=5135763&expiry_in_minutes=5&usersource=paperpal&utm_source=paperpal&utm_medium=website&utm_campaign=organic (accessed on 18 December 2024).
  5. Suryawanshi, O.; Pajai, S. A Comprehensive Review on Postpartum Depression. Cureus 2022, 14, e32745. [Google Scholar] [CrossRef]
  6. Abdollahi, F.; Zarghami, M. Effect of Postpartum Depression on Women’s Mental and Physical Health Four Years After Childbirth. East. Mediterr. Health J. 2018, 24, 1002–1009. [Google Scholar] [CrossRef] [PubMed]
  7. Saharoy, R.; Potdukhe, A.; Wanjari, M.; Taksande, A.B. Postpartum Depression and Maternal Care: Exploring the Complex Effects on Mothers and Infants. Cureus 2023, 15, e41381. [Google Scholar] [CrossRef]
  8. Slomian, J.; Honvo, G.; Emonts, P.; Reginster, J.-Y.; Bruyère, O. Consequences of Maternal Postpartum Depression: A Systematic Review of Maternal and Infant Outcomes. Womens Health 2019, 15, 1745506519844044. [Google Scholar] [CrossRef]
  9. Richards, M.C.; Ferrario, C.A.; Yan, Y.; McDonald, N.M. The Impact of Postpartum Depression on the Early Mother-Infant Relationship during the COVID-19 Pandemic: Perception versus Reality. Int. J. Environ. Res. Public Health 2024, 21, 164. [Google Scholar] [CrossRef]
  10. Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum. Available online: https://www.acog.org/clinical/clinical-guidance/clinical-practice-guideline/articles/2023/06/treatment-and-management-of-mental-health-conditions-during-pregnancy-and-postpartum (accessed on 18 December 2024).
  11. Overview|Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance|Guidance|NICE. Available online: https://www.nice.org.uk/guidance/cg192 (accessed on 18 December 2024).
  12. Husain, N.; Rahman, A.; Husain, M.; Khan, S.M.; Vyas, A.; Tomenson, B.; Cruickshank, K.J. Detecting Depression in Pregnancy: Validation of EPDS in British Pakistani Mothers. J. Immigr. Minor. Health 2014, 16, 1085–1092. [Google Scholar] [CrossRef]
  13. Moraes, G.P.d.A.; Lorenzo, L.; Pontes, G.A.R.; Montenegro, M.C.; Cantilino, A. Screening and Diagnosing Postpartum Depression: When and How? Trends Psychiatry Psychother. 2017, 39, 54–61. [Google Scholar] [CrossRef]
  14. Sakemi, Y.; Nakashima, T.; Watanabe, K.; Ochiai, M.; Sawano, T.; Inoue, H.; Kawakami, K.; Isomura, S.; Yamashita, H.; Ohga, S. Changing Risk Factors for Postpartum Depression in Mothers Admitted to a Perinatal Center. Pediatr. Neonatol. 2023, 64, 319–326. [Google Scholar] [CrossRef] [PubMed]
  15. Maliszewska, K.; Bidzan, M.; Świątkowska-Freund, M.; Preis, K. Medical and Psychosocial Determinants of Risk of Postpartum Depression: A Cross-Sectional Study. Acta Neuropsychiatr. 2017, 29, 347–355. [Google Scholar] [CrossRef]
  16. Florio, A.D.; Putnam, K.; Altemus, M.; Apter, G.; Bergink, V.; Bilszta, J.; Brock, R.; Buist, A.; Deligiannidis, K.M.; Devouche, E.; et al. The Impact of Education, Country, Race and Ethnicity on the Self-Report of Postpartum Depression Using the Edinburgh Postnatal Depression Scale. Psychol. Med. 2017, 47, 787–799. [Google Scholar] [CrossRef]
  17. Posner, N.A.; Unterman, R.R.; Williams, K.N.; Williams, G.H. Screening for Postpartum Depression. An Antepartum Questionnaire. J. Reprod. Med. 1997, 42, 207–215. [Google Scholar]
  18. Wang, L.; Kroenke, K.; Stump, T.E.; Monahan, P.O. Screening for Perinatal Depression with the Patient Health Questionnaire Depression Scale (PHQ-9): A Systematic Review and Meta-Analysis. Gen. Hosp. Psychiatry 2021, 68, 74–82. [Google Scholar] [CrossRef] [PubMed]
  19. Gjerdingen, D.; Crow, S.; McGovern, P.; Miner, M.; Center, B. Postpartum Depression Screening at Well-Child Visits: Validity of a 2-Question Screen and the PHQ-9. Ann. Fam. Med. 2009, 7, 63–70. [Google Scholar] [CrossRef] [PubMed]
  20. Ukatu, N.; Clare, C.A.; Brulja, M. Postpartum Depression Screening Tools: A Review. Psychosomatics 2018, 59, 211–219. [Google Scholar] [CrossRef]
  21. Bödecs, T.; Horváth, B.; Szilágyi, E.; Gonda, X.; Rihmer, Z.; Sándor, J. Effects of Depression, Anxiety, Self-Esteem, and Health Behaviour on Neonatal Outcomes in a Population-Based Hungarian Sample. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 154, 45–50. [Google Scholar] [CrossRef]
  22. Maçola, L.; do Vale, I.N.; Carmona, E.V. Assessment of self-esteem in pregnant women using Rosenberg’s Self-Esteem Scale. Rev. Esc. Enferm. USP 2010, 44, 570–577. [Google Scholar] [CrossRef]
  23. Santos, P.C.; Abreu, S.; Moreira, C.; Santos, R.; Ferreira, M.; Alves, O.; Moreira, P.; Mota, J. Physical Activity Patterns During Pregnancy in a Sample of Portuguese Women: A Longitudinal Prospective Study. Iran. Red Crescent Med. J. 2016, 18, e22455. [Google Scholar] [CrossRef]
  24. Know More. Feel Better. Available online: https://www.verywellhealth.com/ (accessed on 27 February 2025).
  25. Faisal-Cury, A.; Tedesco, J.J.A.; Kahhale, S.; Menezes, P.R.; Zugaib, M. Postpartum Depression: In Relation to Life Events and Patterns of Coping. Arch. Womens Ment. Health 2004, 7, 123–131. [Google Scholar] [CrossRef] [PubMed]
  26. Yu, M.; Gong, W.; Taylor, B.; Cai, Y.; Xu, D. (Roman) Coping Styles in Pregnancy, Their Demographic and Psychological Influences, and Their Association with Postpartum Depression: A Longitudinal Study of Women in China. Int. J. Environ. Res. Public Health 2020, 17, 3654. [Google Scholar] [CrossRef]
  27. Cox, J.L.; Holden, J.M.; Sagovsky, R. Detection of Postnatal Depression: Development of the 10-Item Edinburgh Postnatal Depression Scale. Br. J. Psychiatry 1987, 150, 782–786. [Google Scholar] [CrossRef] [PubMed]
  28. Deligiannidis, K.M.; Meltzer-Brody, S.; Maximos, B.; Peeper, E.Q.; Freeman, M.; Lasser, R.; Bullock, A.; Kotecha, M.; Li, S.; Forrestal, F.; et al. Zuranolone for the Treatment of Postpartum Depression. Am. J. Psychiatry 2023, 180, 668–675. [Google Scholar] [CrossRef]
  29. Does Maternal Role Functioning Improve with Antidepressant Treatment in Women with Postpartum Depression? J. Womens Health 2009, 18, 85–90. [CrossRef]
  30. Diagnostic and Statistical Manual of Mental Disorders: DSM-5TM, 5th ed; American Psychiatric Publishing, Inc.: Arlington, VA, USA, 2013; pp. xliv, 947.
  31. Kroenke, K.; Spitzer, R.L.; Williams, J.B.W. The PHQ-9. J. Gen. Intern. Med. 2001, 16, 606–613. [Google Scholar] [CrossRef]
  32. Larsen, A.; Pintye, J.; Odhiambo, B.; Mwongeli, N.; Marwa, M.M.; Watoyi, S.; Kinuthia, J.; Abuna, F.; Gomez, L.; Dettinger, J.; et al. Comparing Depression Screening Tools (CESD-10, EPDS, PHQ-9, and PHQ-2) for Diagnostic Performance and Epidemiologic Associations among Postpartum Kenyan Women: Implications for Research and Practice. J. Affect. Disord. 2023, 324, 637–644. [Google Scholar] [CrossRef] [PubMed]
  33. Kroenke, K.; Spitzer, R.L.; Williams, J.B.; Löwe, B. An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4—ScienceDirect. Psychosomatics 2009, 50, 613–621. [Google Scholar] [CrossRef]
  34. Wicke, F.S.; Krakau, L.; Löwe, B.; Beutel, M.E.; Brähler, E. Update of the Standardization of the Patient Health Questionnaire-4 (PHQ-4) in the General Population. J. Affect. Disord. 2022, 312, 310–314. [Google Scholar] [CrossRef]
  35. Basu, A.; Kim, H.H.; Basaldua, R.; Choi, K.W.; Charron, L.; Kelsall, N.; Hernandez-Diaz, S.; Wyszynski, D.F.; Koenen, K.C. A Cross-National Study of Factors Associated with Women’s Perinatal Mental Health and Wellbeing during the COVID-19 Pandemic. PLoS ONE 2021, 16, e0249780. [Google Scholar] [CrossRef]
  36. Declercq, E.; Feinberg, E.; Belanoff, C. Racial Inequities in the Course of Treating Perinatal Mental Health Challenges: Results from Listening to Mothers in California. Birth 2022, 49, 132–140. [Google Scholar] [CrossRef] [PubMed]
  37. Rodríguez-Muñoz, M.d.l.F.; Ruiz-Segovia, N.; Soto-Balbuena, C.; Le, H.-N.; Olivares-Crespo, M.E.; Izquierdo-Méndez, N. The Psychometric Properties of the Patient Health Questionnaire-4 for Pregnant Women. Int. J. Environ. Res. Public Health 2020, 17, 7583. [Google Scholar] [CrossRef]
  38. Scalable Screening and Treatment Response Monitoring for Perinatal Depression in Low- and Middle-Income Countries. Available online: https://www.mdpi.com/1660-4601/18/13/6693 (accessed on 18 December 2024).
  39. Barrera, A.Z.; Moh, Y.S.; Nichols, A.; Le, H.-N. The Factor Reliability and Convergent Validity of the Patient Health Questionnaire-4 Among an International Sample of Pregnant Women. J. Womens Health 2021, 30, 525–532. [Google Scholar] [CrossRef]
  40. Tandon, S.D.; Cluxton-Keller, F.; Leis, J.; Le, H.-N.; Perry, D.F. A Comparison of Three Screening Tools to Identify Perinatal Depression among Low-Income African American Women. J. Affect. Disord. 2012, 136, 155–162. [Google Scholar] [CrossRef] [PubMed]
  41. Flynn, H.A.; Sexton, M.; Ratliff, S.; Porter, K.; Zivin, K. Comparative Performance of the Edinburgh Postnatal Depression Scale and the Patient Health Questionnaire-9 in Pregnant and Postpartum Women Seeking Psychiatric Services. Psychiatry Res. 2011, 187, 130–134. [Google Scholar] [CrossRef]
  42. Castro E Couto, T.; Martins Brancaglion, M.Y.; Nogueira Cardoso, M.; Bergo Protzner, A.; Duarte Garcia, F.; Nicolato, R.; Lopes P Aguiar, R.A.; Vitor Leite, H.; Corrêa, H. What Is the Best Tool for Screening Antenatal Depression? J. Affect. Disord. 2015, 178, 12–17. [Google Scholar] [CrossRef]
  43. Hanusa, B.H.; Scholle, S.H.; Haskett, R.F.; Spadaro, K.; Wisner, K.L. Screening for Depression in the Postpartum Period: A Comparison of Three Instruments. J. Womens Health 2002 2008, 17, 585–596. [Google Scholar] [CrossRef]
  44. White, G. A Comparison of the Postpartum Depression Screening Scale (PDSS) with the Edinburgh Postnatal Depression Scale (EPDS). N. Z. Coll. Midwives J. 2008, 39, 28–33. [Google Scholar]
  45. Su, K.-P.; Chiu, T.-H.; Huang, C.-L.; Ho, M.; Lee, C.-C.; Wu, P.-L.; Lin, C.-Y.; Liau, C.-H.; Liao, C.-C.; Chiu, W.-C.; et al. Different Cutoff Points for Different Trimesters? The Use of Edinburgh Postnatal Depression Scale and Beck Depression Inventory to Screen for Depression in Pregnant Taiwanese Women. Gen. Hosp. Psychiatry 2007, 29, 436–441. [Google Scholar] [CrossRef]
  46. Beck, C.T.; Gable, R.K. Comparative Analysis of the Performance of the Postpartum Depression Screening Scale with Two Other Depression Instruments. Nurs. Res. 2001, 50, 242–250. [Google Scholar] [CrossRef]
  47. Gawlik, S.; Waldeier, L.; Müller, M.; Szabo, A.; Sohn, C.; Reck, C. Subclinical Depressive Symptoms during Pregnancy and Birth Outcome—A Pilot Study in a Healthy German Sample. Arch. Womens Ment. Health 2013, 16, 93–100. [Google Scholar] [CrossRef]
  48. Fernandes, M.C.; Srinivasan, K.; Stein, A.L.; Menezes, G.; Sumithra, R.S.; Ramchandani, P.G. Assessing Prenatal Depression in the Rural Developing World: A Comparison of Two Screening Measures. Arch. Womens Ment. Health 2011, 14, 209–216. [Google Scholar] [CrossRef] [PubMed]
  49. Tesfaye, M.; Hanlon, C.; Wondimagegn, D.; Alem, A. Detecting Postnatal Common Mental Disorders in Addis Ababa, Ethiopia: Validation of the Edinburgh Postnatal Depression Scale and Kessler Scales. J. Affect. Disord. 2010, 122, 102–108. [Google Scholar] [CrossRef]
  50. Matthey, S.; Souter, K.; Valenti, B.; Ross-Hamid, C. Validation of the MGMQ in Screening for Emotional Difficulties in Women during Pregnancy. J. Affect. Disord. 2019, 256, 156–163. [Google Scholar] [CrossRef]
  51. Naja, S.; Al-Kubaisi, N.; Chehab, M.; Al-Dahshan, A.; Abuhashem, N.; Bougmiza, I. Psychometric Properties of the Arabic Version of EPDS and BDI-II as a Screening Tool for Antenatal Depression: Evidence from Qatar. BMJ Open 2019, 9, e030365. [Google Scholar] [CrossRef] [PubMed]
  52. Chorwe-Sungani, G. Validity and Utility of Instruments for Screening of Depression in Women Attending Antenatal Clinics in Blantyre District in Malawi. S. Afr. Fam. Pract. 2018, 60, 114–120. [Google Scholar] [CrossRef]
  53. Green, E.P.; Tuli, H.; Kwobah, E.; Menya, D.; Chesire, I.; Schmidt, C. Developing and Validating a Perinatal Depression Screening Tool in Kenya Blending Western Criteria with Local Idioms: A Mixed Methods Study. J. Affect. Disord. 2018, 228, 49–59. [Google Scholar] [CrossRef]
  54. van Heyningen, T.; Honikman, S.; Tomlinson, M.; Field, S.; Myer, L. Comparison of Mental Health Screening Tools for Detecting Antenatal Depression and Anxiety Disorders in South African Women. PLoS ONE 2018, 13, e0193697. [Google Scholar] [CrossRef]
  55. Carver, C.S.; Scheier, M.F.; Weintraub, J.K. Assessing Coping Strategies: A Theoretically Based Approach. J. Pers. Soc. Psychol. 1989, 56, 267–283. [Google Scholar] [CrossRef]
  56. Jayaseelan, J.; Mohan, M.P. Coping Strategies Used by Postnatal Mothers with Perceived Stress. Indian J. Psychiatry 2020, 62, 451–452. [Google Scholar] [CrossRef]
  57. Kim, H.-S.; Chung, M.-Y.; Rhee, E.S.; Kim, Y. Is It Reciprocating or Self-Serving?: Understanding Coping Strategies for Postpartum Depression in an Online Community for Korean Mothers. Health Care Women Int. 2022, 43, 1464–1481. [Google Scholar] [CrossRef] [PubMed]
  58. Azale, T.; Fekadu, A.; Medhin, G.; Hanlon, C. Coping Strategies of Women with Postpartum Depression Symptoms in Rural Ethiopia: A Cross-Sectional Community Study. BMC Psychiatry 2018, 18, 41. [Google Scholar] [CrossRef]
  59. DeFoor, M.; Amiri, A. A Conceptual Analysis of Mental Health Maladaptation in Postpartum. J. Perinat. Educ. 2023, 32, 14. [Google Scholar] [CrossRef]
  60. Han, J.-W.; Kim, D.-J. Longitudinal Relationship Study of Depression and Self-Esteem in Postnatal Korean Women Using Autoregressive Cross-Lagged Modeling. Int. J. Environ. Res. Public Health 2020, 17, 3743. [Google Scholar] [CrossRef]
  61. Altamura, M.; Leccisotti, I.; Masi, L.D.; Gallone, F.; Ficarella, L.; Severo, M.; Biancofiore, S.; Denitto, F.; Ventriglio, A.; Petito, A.; et al. Coping as a Mediator between Attachment and Depressive Symptomatology Either in Pregnancy or in the Early Postpartum Period: A Structural Equation Modelling Approach. Brain Sci. 2023, 13, 1002. [Google Scholar] [CrossRef] [PubMed]
  62. Walker, L.O.; Murry, N. Maternal Stressors and Coping Strategies During the Extended Postpartum Period: A Retrospective Analysis with Contemporary Implications. Womens Health Rep. 2022, 3, 104–114. [Google Scholar] [CrossRef]
  63. Kinser, P.A.; Jallo, N.; Amstadter, A.B.; Thacker, L.R.; Jones, E.; Moyer, S.; Rider, A.; Karjane, N.; Salisbury, A.L. Depression, Anxiety, Resilience, and Coping: The Experience of Pregnant and New Mothers During the First Few Months of the COVID-19 Pandemic. J. Womens Health 2021, 30, 654–664. [Google Scholar] [CrossRef]
  64. Moshki, M.; Beydokhti, T.B.; Cheravi, K. The Effect of Educational Intervention on Prevention of Postpartum Depression: An Application of Health Locus of Control. J. Clin. Nurs. 2014, 23, 2256–2263. [Google Scholar] [CrossRef]
  65. Alshowkan, A.; Shdaifat, E.; Alnass, F.A.; Alqahtani, F.M.; AlOtaibi, N.G.; AlSaleh, N.S. Coping Strategies in Postpartum Women: Exploring the Influence of Demographic and Maternity Factors. BMC Womens Health 2023, 23, 582. [Google Scholar] [CrossRef]
  66. Rinne, G.R.; Guardino, C.M.; Soriano, M.; Dunkel Schetter, C. Chronic Stress and Hair Cortisol Concentration in Mothers: A Two-Study Investigation. Stress Health 2024, 40, e3493. [Google Scholar] [CrossRef]
  67. Iliadis, S.I.; Comasco, E.; Sylvén, S.; Hellgren, C.; Poromaa, I.S.; Skalkidou, A. Prenatal and Postpartum Evening Salivary Cortisol Levels in Association with Peripartum Depressive Symptoms. PLoS ONE 2015, 10, e0135471. [Google Scholar] [CrossRef]
  68. Ristanovic, I.; Vargas, T.G.; Damme, K.S.F.; Mittal, V.A. Hippocampal Subfields, Daily Stressors, and Resting Cortisol in Individuals at Clinical High-Risk for Psychosis. Psychoneuroendocrinology 2023, 148, 105996. [Google Scholar] [CrossRef]
  69. Horáková, A.; Němcová, H.; Mohr, P.; Sebela, A. Structural, Functional, and Metabolic Signatures of Postpartum Depression: A Systematic Review. Front. Psychiatry 2022, 13, 1044995. [Google Scholar] [CrossRef]
  70. Edwards, I. Brain Changes May Help Explain Postpartum Depression. Available online: https://medicalxpress.com/news/2025-03-brain-postpartum-depression.html (accessed on 27 April 2025).
  71. Zoccola, P.M.; Dickerson, S.S.; Zaldivar, F.P. Rumination and Cortisol Responses to Laboratory Stressors. Biopsychosoc. Sci. Med. 2008, 70, 661–667. [Google Scholar] [CrossRef]
  72. Zoccola, P.M.; Figueroa, W.S.; Rabideau, E.M.; Woody, A.; Benencia, F. Differential Effects of Poststressor Rumination and Distraction on Cortisol and C-Reactive Protein. Health Psychol. 2014, 33, 1606–1609. [Google Scholar] [CrossRef]
  73. Peñacoba Puente, C.; Suso-Ribera, C.; Blanco Rico, S.; Marín, D.; San Román Montero, J.; Catalá, P. Is the Association between Postpartum Depression and Early Maternal–Infant Relationships Contextually Determined by Avoidant Coping in the Mother? Int. J. Environ. Res. Public Health 2021, 18, 562. [Google Scholar] [CrossRef] [PubMed]
  74. Gray-Little, B.; Williams, V.S.L.; Hancock, T.D. An Item Response Theory Analysis of the Rosenberg Self-Esteem Scale. Pers. Soc. Psychol. Bull. 1997, 23, 443–451. [Google Scholar] [CrossRef]
  75. Zhang, L.; Yu, Q.; Zhang, Q.; Guo, Y.; Chen, J. The Relationship between Explicit Self-Esteem and Subjective Well-Being: The Moderating Effect of Implicit Self-Esteem. J. Gen. Psychol. 2020, 147, 1–17. [Google Scholar] [CrossRef]
  76. Definition of SELF-ESTEEM. Available online: https://www.merriam-webster.com/dictionary/self-esteem (accessed on 27 February 2025).
  77. García, J.A.; Y Olmos, F.C.; Matheu, M.L.; Carreño, T.P. Self Esteem Levels vs Global Scores on the Rosenberg Self-Esteem Scale. Heliyon 2019, 5, e01378. [Google Scholar] [CrossRef]
  78. Harris, M.A.; Orth, U. The Link between Self-Esteem and Social Relationships: A Meta-Analysis of Longitudinal Studies. J. Personal. Soc. Psychol. 2020, 119, 1459–1477. [Google Scholar] [CrossRef]
  79. Zeigler-Hill, V. The Importance of Self-Esteem. In Self-Esteem; Psychology Press: Hove, UK, 2013. [Google Scholar]
  80. Orth, U.; Robins, R.W. Development of Self-Esteem across the Lifespan. In Handbook of Personality Development; The Guilford Press: New York, NY, USA, 2019; pp. 328–344. [Google Scholar]
  81. Sowislo, J.F.; Orth, U. Does Low Self-Esteem Predict Depression and Anxiety? A Meta-Analysis of Longitudinal Studies. Psychol. Bull. 2013, 139, 213–240. [Google Scholar] [CrossRef] [PubMed]
  82. Shoraka, H.; Amirkafi, A.; Garrusi, B. Review of Body Image and Some of Contributing Factors in Iranian Population. Int. J. Prev. Med. 2019, 10, 19. [Google Scholar] [CrossRef] [PubMed]
  83. Rahmanian, V.; Zolala, F.; Mohseni, M.; Baneshi, M.; KHalili, N. Relationship between Body Image and Social Participation in Pregnant Women of Jahrom City, Iran. Intern. Med. Today 2017, 23, 111–116. [Google Scholar] [CrossRef]
  84. Boscaglia, N.; Skouteris, H.; Wertheim, E.H. Changes in Body Image Satisfaction during Pregnancy: A Comparison of High Exercising and Low Exercising Women. Aust. N. Z. J. Obstet. Gynaecol. 2003, 43, 41–45. [Google Scholar] [CrossRef]
  85. Williams, K. The Relationship between Body Image and Mother to Infant Attachment in the Postpartum Period. Ph.D. Thesis, University of Leeds, Leeds, UK, 2019. [Google Scholar]
  86. Heshmati, R.; Khodaparast, S. The Predictive Role of Body Image, Body Mass Index, Dispositional Mindfulness and Alexithymia in Marital Satisfaction of Employed Women. Womens Stud. Sociol. Psychol. 2017, 14, 43–68. [Google Scholar] [CrossRef]
  87. Paans, N.P.G.; Bot, M.; Brouwer, I.A.; Visser, M.; Penninx, B.W.J.H. Contributions of Depression and Body Mass Index to Body Image. J. Psychiatr. Res. 2018, 103, 18–25. [Google Scholar] [CrossRef]
  88. Garrusi, B.; Razavi Nematallahee, V.; Etminan, A. The Relationship of Body Image with Depression and Self-Esteem in Pregnant Women. Health Dev. J. 2013, 2, 117–127. [Google Scholar]
  89. Chan, C.Y.; Lee, A.M.; Koh, Y.W.; Lam, S.K.; Lee, C.P.; Leung, K.Y.; Tang, C.S.K. Associations of Body Dissatisfaction with Anxiety and Depression in the Pregnancy and Postpartum Periods: A Longitudinal Study. J. Affect. Disord. 2020, 263, 582–592. [Google Scholar] [CrossRef]
  90. Morley-Hewitt, A.G.; Owen, A.L. A Systematic Review Examining the Association between Female Body Image and the Intention, Initiation and Duration of Post-Partum Infant Feeding Methods (Breastfeeding vs Bottle-Feeding). J. Health Psychol. 2020, 25, 207–226. [Google Scholar] [CrossRef]
  91. Vakilian, K.; Poorjandaghi, M.; Khorsandi, M. Effectiveness of Cognitive Group Counseling to Self-Esteem in Nulliparous Women. Majallah-Bālīnī-Parastārī Māmāī 2018, 7, 67–74. [Google Scholar]
  92. Brown, T.A.; Cash, T.F.; Mikulka, P.J. Attitudinal Body-Image Assessment: Factor Analysis of the Body-Self Relations Questionnaire. J. Pers. Assess. 1990, 55, 135–144. [Google Scholar] [CrossRef]
  93. Amel, B.M.; Nahid, M. Self Esteem and Its Associated Factors in Primiparous Mothers Referred to Health Centers in the City of Mashhad. J. Clin. Nurs. Midwifery 2016, 5, 19–28. [Google Scholar]
  94. Behdarvandi, M.; Azarbarzin, M.; Baraz, S. Comparison of Body Image and Its Relationship with Body Mass Index (BMI) in High School Students of Ahvaz, Iran. Int. J. Pediatr. 2017, 5, 4353–4360. [Google Scholar] [CrossRef]
  95. Maryam, F.; Mohammad, E.M.; Javad, K. The Effectiveness Acceptance and Commitment Group Therapy and Cognitive- Behavior Group Therapy on Perfectionism and Self-Esteem Women with Body Image Dissatisfaction. Clin. Psychol. Personal. 2020, 17, 89–100. [Google Scholar] [CrossRef]
  96. Alireza, B.; Mohammad, B.K.; Abolghasem, N.; Mohammad, R.A. The Impact of Lived-Experience Based Therapy and Cognitive-Behavior Therapy on Body Mass Index and Self-Esteem among Obese Women. Int. J. Appl. Behav. Sci. 2019, 6, 52–60. [Google Scholar] [CrossRef]
  97. Mekereș, G.M.; Buhaș, C.L.; Tudoran, C.; Csep, A.N.; Tudoran, M.; Manole, F.; Iova, C.S.; Pop, N.O.; Voiţă, I.B.; Domocoș, D.; et al. The Practical Utility of Psychometric Scales for the Assessment of the Impact of Posttraumatic Scars on Mental Health. Front. Public Health 2023, 11, 1103714. [Google Scholar] [CrossRef]
  98. Voiță-Mekeres, F.; Buhaș, C.L.; Mekeres, G.M.; Tudoran, C.; Racovita, M.; Faur, C.I.; Tudoran, M.; Abu-Awwad, A.; Voiță, N.C.; Maghiar, T.A. Mekeres’ Psychosocial Internalization Scale: A Scale for the Evaluation of Aesthetic Prejudice in Victims of Accidents and Violence. Healthcare 2021, 9, 1440. [Google Scholar] [CrossRef]
  99. Mekeres, G.M.; Buhaș, C.L.; Bulzan, M.; Marian, P.; Hozan, C.T. Objective Criteria in Evaluating the Consequences of the Posttraumatic Scars. Pharmacophore 2022, 13, 56–61. [Google Scholar] [CrossRef]
  100. Mekeres, G.M.; Buhaș, C.L.; Csep, A.N.; Beiușanu, C.; Andreescu, G.; Marian, P.; Cheregi, C.D.; Fodor, R.; Manole, F. The Importance of Psychometric and Physical Scales for the Evaluation of the Consequences of Scars—A Literature Review. Clin. Pract. 2023, 13, 372–383. [Google Scholar] [CrossRef]
  101. Eisenbarth, C. Does Self-Esteem Moderate the Relations Among Perceived Stress, Coping, and Depression? |EBSCOhost. Available online: https://openurl.ebsco.com/contentitem/gcd:73951026?sid=ebsco:plink:crawler&id=ebsco:gcd:73951026 (accessed on 1 March 2025).
  102. Amestoy, M.E.; D’Amico, D.; Fiocco, A.J. Neuroticism and Stress in Older Adults: The Buffering Role of Self-Esteem. Int. J. Environ. Res. Public Health 2023, 20, 6102. [Google Scholar] [CrossRef]
  103. Di Blas, L.; Borella, M.; Ferrante, D. Short-Term Effects of Fluctuations in Self-Esteem, Perceived Stress and Loneliness on Depressive States. Psihol. Teme 2021, 30, 99–114. [Google Scholar] [CrossRef]
  104. Orth, U.; Robins, R.W.; Trzesniewski, K.H.; Maes, J.; Schmitt, M. Low Self-Esteem Is a Risk Factor for Depressive Symptoms from Young Adulthood to Old Age. J. Abnorm. Psychol. 2009, 118, 472. [Google Scholar] [CrossRef] [PubMed]
  105. Badr, H.; Albargi, N.A.; Alsharif, N.H.; Sharahili, M.M.; Kherd, N.K. The Relationship between Perceived Social Support, Self-Esteem, and Postpartum Depression among Saudi Women: A Correlational Cross-Sectional Study. J. Healthc. Adm. 2024, 3, 100–112. [Google Scholar] [CrossRef]
  106. Al-Amer, R.M.; Malak, M.Z.; Darwish, M.M. Self-Esteem, Stress, and Depressive Symptoms among Jordanian Pregnant Women: Social Support as a Mediating Factor. Women Health 2022, 62, 412–420. [Google Scholar] [CrossRef] [PubMed]
  107. Li, W.; Lu, C. Reciprocal Relationships between Self-Esteem, Coping Styles and Anxiety Symptoms among Adolescents: Between-Person and within-Person Effects. Eur. Psychiatry 2023, 66, S748. [Google Scholar] [CrossRef]
  108. Kwok, G.; Tam, C.L. Depression, Self-Esteem, and Lifestyle Factors Among University Students in Singapore and Malaysia. Int. J. Inf. Syst. Soc. Change IJISSC 2023, 14, 1–18. [Google Scholar] [CrossRef]
  109. Kim, D. Relationships between Caregiving Stress, Depression, and Self-Esteem in Family Caregivers of Adults with a Disability. Occup. Ther. Int. 2017, 2017, 1686143. [Google Scholar] [CrossRef]
Figure 1. Conceptual framework of postpartum depression (PPD) screening, psychosocial factors, and health outcomes.
Figure 1. Conceptual framework of postpartum depression (PPD) screening, psychosocial factors, and health outcomes.
Diagnostics 15 01152 g001
Table 1. Inclusion and exclusion criteria.
Table 1. Inclusion and exclusion criteria.
Inclusion CriteriaExclusion Criteria
Studies involving pregnant or postpartum womenStudies focusing solely on treatment outcomes without validation data
Use of validated depression screening tools (EPDS, PHQ-9, PHQ-2, PHQ-4)Case reports, editorials, conference abstracts, or non-peer-reviewed sources
Reporting validation metrics (sensitivity, specificity, cutoff scores)Studies lacking sufficient quantitative data
Incorporation of psychosocial assessments (RSES, COPE Inventory)Articles not available in English or as full texts
Table 2. EDPS validations studies.
Table 2. EDPS validations studies.
YearAuthorsLocationSubjectsAge (Mean ± SD)Weeks
Pregnant/Postpartum
Total (n)ScalesCutoffSensitivity (95% CI)Specificity (95% CI)
2008Hanusa et al. [43]USAPostpartum women30.1 ± 5.86–829EPDS≥100.62 (0.36–0.82)0.88 (0.64–0.97)
2008Hanusa et al. [43]USAPostpartum women30.1 ± 5.86–829PHQ-9≥100.31 (0.13–0.58)0.06 (0.01–0.28)
2001White [44]New
Zealand
Postpartum women33.0 ± 4.67.9 ± 5.1 (2–29)60EPDS≥90.70 (0.48–0.85)0.92 (0.80–0.97)
2001Su et al.
[45]
TaiwanPregnant women32.0 ± 4.02–3 trimester (2nd 49.7%)185EPDS≥130.83 (0.63–0.93)0.89 (0.83–0.93)
2001Beck et al. [46]USAPostpartum women31.0 ± 4.82–12150EPDS≥120.78 (0.64–0.88)0.99 (0.95–1.00)
2013Gawlik et al. [47]GermanyPregnant women32.8 ± 4.631.8 ± 4.2273EPDS≥120.80 (0.38–0.96)0.88 (0.84–0.91)
2012Tandon et al. [40]USAPregnant and postpartum women24.4 ± 5.831.0 ± 7.3/8.2 ± 3.195EPDS≥130.81 (0.63–0.92)0.98 (0.88–0.98)
2011Fernandes et al. [48]UKPregnant women21.5 ± 2.635.0 ± 3.0194EPDS≥131.00 (0.88–1.00)0.85 (0.79–0.90)
2011Flynn et al. [41]USAPregnant women30.0 ± 8.721.0 ± 9.081EPDS≥130.79 (0.67–0.88)0.74 (0.54–0.87)
2011Flynn et al. [41]USAPostpartum women31.0 ± 6.012.0 ± 11.081EPDS≥130.92 (0.84–0.96)0.54 (0.36–0.70)
2010Tesfaye et al. [49]UKPostpartum women25.3 ± 5.110–14100EPDS≥7/80.82 (0.52–0.95)0.78 (0.68–0.85)
2019Matthey et al. [50]AustraliaPregnant women28.4 ± 5.014.2 ± 3.8252EPDS≥100.67 (0.50–0.80)0.97 (0.94–0.99)
2019Naja et al. [51]QatarPregnant women28.8 ± 5.01–3 trimester (2nd 48.4%)128EPDS≥130.86 (0.71–0.94)0.90 (0.83–0.95)
2018Chorwe-Sungani et al. [52]South
Africa
Pregnant women25.8 ± 5.227.7 ± 7.997EPDS≥100.68 (0.48–0.83)0.88 (0.78–0.93)
2018Green et al. [53]KenyaPregnant and postpartum women27.1 ± 5.92–3 trimester (4–24)193EPDS≥160.70 (0.40–0.89)0.72 (0.65–0.78)
2018van Heyningen et al.
[54]
South
Africa
Pregnant women26.8 ± 5.91–3 trimester (2nd 46.5%)376EPDS≥140.86 (0.76–0.92)0.81 (0.76–0.85)
2015Castro et al. [42]BrazilPregnant women20–39 (80%)2nd trimester245EPDS≥110.81 (0.67–0.90)0.74 (0.67–0.79)
Table 3. PHQ validation studies.
Table 3. PHQ validation studies.
YearAuthorsLocationSubjectsAge (Mean ± SD)Weeks Pregnant/PostpartumGold StandardBlindTotal (n)ScalesCutoffSensitivity (95% CI)Specificity (95% CI)
2008Hanusa et al. [43]USAPostpartum women30.1 ± 5.86–8SCIDUnknown29PHQ-9≥100.31 (0.13–0.58)0.06 (0.01–0.28)
2013Gawlik et al. [47]GermanyPregnant women32.8 ± 4.631.8 ± 4.2SCIDUnknown273PHQ-9≥100.40 (0.12–0.77)0.92 (0.88–0.95)
2011Flynn et al. [41]USAPostpartum women31.0 ± 6.012.0 ± 11.0DSM-IVUnknown81PHQ-9≥100.89 (0.81–0.95)0.64 (0.46–0.79)
2018Green et al. [53]KenyaPregnant and postpartum women27.1 ± 5.92–3 trimester (4–24)DSM-5Yes193PHQ-9≥150.70 (0.40–0.89)0.74 (0.67–0.80)
2018van Heyningen et al. [54]South
Africa
Pregnant women26.8 ± 5.91–3 trimester (2nd 46.5%)MINI+Unknown376PHQ-9≥100.80 (0.70–0.87)0.82 (0.77–0.86)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Motofelea, N.; Motofelea, A.C.; Tamasan, I.F.; Hoinoiu, T.; Ioana, J.T.M.; Vilibić, M.; Cringu, A.I.; Bernad, B.C.; Trinc, S.; Navolan, D.-B. Predictive Validity of Screening Tools and Role of Self-Esteem and Coping in Postpartum Depression Risk. Diagnostics 2025, 15, 1152. https://doi.org/10.3390/diagnostics15091152

AMA Style

Motofelea N, Motofelea AC, Tamasan IF, Hoinoiu T, Ioana JTM, Vilibić M, Cringu AI, Bernad BC, Trinc S, Navolan D-B. Predictive Validity of Screening Tools and Role of Self-Esteem and Coping in Postpartum Depression Risk. Diagnostics. 2025; 15(9):1152. https://doi.org/10.3390/diagnostics15091152

Chicago/Turabian Style

Motofelea, Nadica, Alexandru Catalin Motofelea, Ionela Florica Tamasan, Teodora Hoinoiu, Jabri Tabrizi Madalina Ioana, Maja Vilibić, Antoniu Ionescu Cringu, Brenda Cristiana Bernad, Sorin Trinc, and Dan-Bogdan Navolan. 2025. "Predictive Validity of Screening Tools and Role of Self-Esteem and Coping in Postpartum Depression Risk" Diagnostics 15, no. 9: 1152. https://doi.org/10.3390/diagnostics15091152

APA Style

Motofelea, N., Motofelea, A. C., Tamasan, I. F., Hoinoiu, T., Ioana, J. T. M., Vilibić, M., Cringu, A. I., Bernad, B. C., Trinc, S., & Navolan, D.-B. (2025). Predictive Validity of Screening Tools and Role of Self-Esteem and Coping in Postpartum Depression Risk. Diagnostics, 15(9), 1152. https://doi.org/10.3390/diagnostics15091152

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop